CHIPTS - Center for HIV Identification, Prevention and Treatment Services

11/20/2025

A reminder to share any comments on the CDC by December 1st. To have the greatest impact, please share your role in HIV care and explain the importance of surveillance data to strengthen your efforts to end the HIV epidemic. Submit here: https://idsociety.quorum.us/campaign/143786/

The deadline to comment is Dec. 1, 2025.

11/19/2025

Applications are now open for 's Visiting Scholars in HIV Implementation Science Program! Early to mid-career and Scholars will receive expert mentorship and build or strengthen community partnerships. Apply by Sunday, January 4, 2026: http://tinyurl.com/3dyp67f6

11/18/2025

Check out this exciting virtual panel hosted by Center for Interdisciplinary Research on AIDS at Yale University in honor of World AIDS Day ( ) on December 2, 2025, at 9AM ET! Panelists will discuss their current research and approaches to addressing the syndemic. Register here: https://yale.zoom.us/meeting/register/99AmJ2skSK2aGWKHuldoLw

11/18/2025

Explore the Research Document Library that connects early-career investigators with examples of successful study protocols, detailed procedures, and other documentation to support the development of their own study design. Learn more: https://sph.emory.edu/news/new-online-tool-helps-early-career-investigators-launch-hiv-research-projects

Calling all early-career HIV investigators & CBOs who are engaged in HIV research!

📚 Check out the HIV Research Document Library with 300+ protocols, SOPs, & study docs from funded HIV research. Free + publicly available to support your grant proposals.

Details → https://buff.ly/DjUaZPi

11/14/2025

Check out this policy brief by California HIV / AIDS Policy Research Centers that provides California pharmacists’ perspectives on implementing prevention services. California pharmacists identified financial concerns as a barrier to implementing pharmacist-initiated services authorized under California Senate Bill (SB) 159/339. Read here: https://chprc.org/publications/law-and-policy-interventions-addressing-pharmacy-benefit-manager-pbm-practices-impact-on-pharmacy-based-hivprevention-services/?fbclid=IwY2xjawOEVuxleHRuA2FlbQIxMABicmlkETFGa2dPOXhEWE5HdXlKZFJRc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHgPvxoB8iu1BUqikJn2oKsPo7xyuwj-3VZMCKaGXqqTxyixWauD7V9Ww5kso_aem_eHT3h_MmcNRF40-3ED3LvA

Ever wonder why drug prices are so high? Pharmacy benefit managers (PBMs) sit between you, your pharmacy, and drug companies—and California's new law SB 41 looks to change how PBMs keep the savings for themselves. Learn more about how these middlemen affect what you pay for your prescriptions.

Governor Newsom signs SB 41 to lower the cost of prescription drugs: https://lnkd.in/gYy7uC3W

Policy Brief: https://chprc.org/publications/law-and-policy-interventions-addressing-pharmacy-benefit-manager-pbm-practices-impact-on-pharmacy-based-hivprevention-services/

11/13/2025

Check out the upcoming on Dec 16th, at 11AM PT, at BSRB 154 or via Zoom! Dr. Hunt (UCSF Bay Area Center for AIDS Research) will review the evidence supporting a potential role of asymptomatic CMV co-infection as a driver of morbidity and mortality in people treated with . Register: https://uclahs.zoom.us/meeting/register/tJEqc-yqrDMsG9dTM3-wm68l7NkjGmhK6vq1

11/13/2025

CAB members and researchers from 8 ARCs came together to attend the National ARC CAB meeting on Nov 8-9, 2025 in Washington, DC. CHIPTS was proud to be a part of the rich and authentic discussion to ensure that community voice is always at the forefront of HIV research.

11/11/2025

We are excited to co-sponsor an upcoming and Seminar with the UCLA-CDU CFAR on Nov. 17, 2025, at 12PM PT entitled “Epigenetic Insights and Translation Opportunities from the MWCCS” featuring Methods Core Scientist, Dr. Christina Ramirez. Join here: https://tinyurl.com/r4t7j48f

11/04/2025

Join UCLA-CDU for the latest Clinical Discovery Seminar on "Studying Cardiovascular Risk and Outcomes among in the Network of Integrated Clinical Systems Cohort (CNICS)," featuring Dr. Durstenfeld on November 13, 2025, at 12 PM PT. RSVP: https://tinyurl.com/3jyucrny

10/31/2025

The UCLA CFAR Methods in Research Scientific Working Group are hosting a community meeting on November 12, 2025 at 12PM PT to share ideas for AI-related HIV research collaborations and explore mentoring and career development opportunities. Join: https://uclahs.zoom.us/j/4843020979?omn=96344397296

10/30/2025

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the revolutionary twice-a-year anti-HIV jab, lenacapavir (LEN), that could bring an end to Aids if enough people take it.

10/29/2025

Check out this issue brief by NASTAD that shares key findings from a survey, illustrating nationwide implications of the proposed cuts of federal funding in sustaining , , and related programs. Read here: https://nastad.org/resources/impact-proposed-federal-budget-cuts-health-departments

📚 NASTAD released an issue brief on the impact of proposed federal budget cuts on health departments.

🔗 Download and read the issue brief here: https://nastad.org/resources/impact-proposed-federal-budget-cuts-health-departments.

"The threat of significant federal funding cuts to public health programs has created growing uncertainty for state and local health departments. Proposed reductions and/or eliminations to CDC’s prevention and surveillance programs, the Ending the HIV Epidemic (EHE) initiative, the HIV/AIDS Program, and would have far-reaching consequences for public health infrastructure and service delivery.

To understand the scope of these potential impacts, NASTAD conducted a jurisdictional impact survey assessing how health departments would be affected by reductions across HIV prevention and surveillance, viral , Ryan White HIV/AIDS Program ( ), and overdose prevention programs.

NASTAD published an issue brief that summarizes key findings from that survey, illustrating nationwide implications of the proposed cuts and underscoring the critical role of federal funding in sustaining HIV, hepatitis, and related public health programs."